2岁以下血友病婴幼儿的临床与治疗特征
分析美国血友病治疗中心登记的883例≤2岁血友病A和B婴幼儿,生命最初2年内颅内出血68例(7.7%),其中8例(11.8%)出血时正在接受持续预防治疗;预防治疗通常在第一年内开始(平均10.3个月),已知阳性家族史与更早诊断和阴道分娩率降低相关;研究强调颅内出血率仍较高,需进一步研究可改变的危险因素以通过更早诊断和更早开始预防来预防颅内出血。
要点
- 883例≤2岁血友病婴幼儿中,生命最初2年颅内出血68例(7.7%),其中8例(11.8%)出血时正在接受持续预防治疗。
- 婴幼儿通常在第一年内开始预防治疗(平均10.3个月),血友病A later出生队列的预防开始年龄更早。
- 与无血友病家族史者相比,已知阳性家族史与更早诊断年龄(P≤.0001)和阴道分娩率降低(P=.0006)相关。
核心结论
- 研究强调≤2岁血友病婴幼儿的颅内出血率仍较高,需进一步研究可改变的危险因素,以通过更早诊断和更早开始预防(即使在生命第一个月内)来预防颅内出血。
研究设计与样本
- 对在美国血友病治疗中心就诊并登记于社区计数登记处(美国疾病控制与预防中心的一个监测项目)的883例≤2岁血友病A和B婴幼儿的临床和人口学特征进行分析。
主要发现
- 生命最初2年内颅内出血见于883例中的68例(7.7%),其中68例中的8例(11.8%)在颅内出血时正在接受持续预防治疗。
- 本研究中婴幼儿通常在第一年内开始预防治疗(平均10.3个月),血友病A婴幼儿在较晚出生队列中预防开始年龄更早。
- 与无血友病家族史者相比,已知阳性血友病家族史与更早诊断年龄(P≤.0001)和阴道分娩率降低(P=.0006)相关。
- 血友病A和B婴幼儿在较晚出生队列中,因子VIII模拟物和延长半衰期凝血因子预防治疗的使用增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infants and toddlers (ITs) with hemophilia have unique bleeding features. Factor prophylaxis has been shown to decrease the risk of intracranial hemorrhage (ICH), which supports recommendations to begin at a young age. Clinical and demographic characteristics were analyzed for 883 ITs ≤2 years old with hemophilia A and B, seen at US Hemophilia Treatment Centers and enrolled in the Community Counts Registry, a surveillance program of the Centers for Disease Control and Prevention. ICH in the first 2 years of life was seen in 68 of 883 (7.7%) ITs, of whom 8 of 68 (11.8%) were on continuous prophylaxis at the time of ICH. ITs in this study usually started prophylaxis within the first year of life (mean, 10.3 months), with earlier ages of prophylaxis initiation in later birth cohorts in ITs with hemophilia A. Compared with those without a family history (FH) of hemophilia, known positive FH of hemophilia was associated with earlier age of diagnosis (P ≤ .0001) and decreased rates of vaginal delivery (P = .0006). The use of factor VIII mimetics and extended half-life clotting factor prophylaxis increased with later birth cohorts for ITs with hemophilia A and B. The study highlights that ICH rates in ITs with hemophilia remains substantial and underscores the need for further research to identify modifiable risk factors to prevent ICH by earlier diagnosis and initiating prophylaxis early, even within the first month of life.
引用
- Han JH, Dupervil B, Mahajerin A, et al. Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia. Blood Adv. 2024. PMID: 38547443. doi:10.1182/bloodadvances.2023012486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。